Abstract:Previous efforts to determine whether or not the transcription factor and tumor suppressor protein p53 is required for DNA damage-induced apoptosis in pluripotent embryonic stem cells (ESCs) produced contradictory conclusions. To resolve this issue, p53+/+ and p53-/- ESCs derived by two different methods were used to quantify time-dependent changes in nuclear DNA content; annexin-V binding; cell permeabilization; and protein expression, modification, and localization. The results revealed that doxorubicin (Adriamycin [ADR]) concentrations 10 to 40 times less than commonly used in previous studies induced the DNA damage-dependent G2-checkpoint and completed apoptosis within the same time frame, regardless of the presence or absence of p53, p21, and PUMA. Increased ADR concentrations delayed initiation of apoptosis in p53-/- ESCs, but the rates of apoptosis remained equivalent. Similar results were obtained by inducing apoptosis with either staurosporine inhibition of kinase activities or WX8 disruption of lysosome homeostasis. Differentiation of ESCs by LIF deprivation revealed p53-dependent formation of haploid cells, increased genomic stability, and suppression of the G2-checkpoint. Minimal induction of DNA damage now resulted in p53-facilitated apoptosis, but regulation of pluripotent gene expression remained p53-independent. Primary embryonic fibroblasts underwent p53-dependent total cell cycle arrest (a prelude to cell senescence), and p53-independent apoptosis occurred in the presence of 10-fold higher levels of ADR, consistent with previous studies. Taken together, these results reveal that the multiple roles of p53 in cell cycle regulation and apoptosis are first acquired during pluripotent stem cell differentiation.

Ets1 is Required for P53 Transcriptional Activity in Uv-Induced Apoptosis in Embryonic Stem Cells

P53 Transcriptional Activity is Essential for P53-Dependent Apoptosis Following DNA Damage

Ultraviolet-Induced Apoptosis in Embryonic Stem Cells in Vitro

P53 and P73 Regulate Apoptosis but Not Cell-Cycle Progression in Mouse Embryonic Stem Cells Upon DNA Damage and Differentiation

A Genomewide Study Identifies the Wnt Signaling Pathway As a Major Target of P53 in Murine Embryonic Stem Cells

P53 Induces Differentiation of Mouse Embryonic Stem Cells by Suppressing Nanog Expression

Ribosomal stress induces 2-cell embryo-like state transition of the mouse ESCs through p53 activation

Regulation of Apoptosis and Differentiation by P53 in Human Embryonic Stem Cells*

Cell cycle arrest and apoptosis are not dependent on p53 prior to p53-dependent embryonic stem cell differentiation

Regulation of Bax activation and apoptotic response to UV irradiation by p53 transcription-dependent and -independent pathways.

An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells.

A New Role for P53 in Maintaining Genetic Stability in Embryonic Stem Cells

ESF1 positively regulates MDM2 and promotes tumorigenesis

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Dna Damage-Induced Apoptosis Requires the Dna-Dependent Protein Kinase, and is Mediated by the Latent Population of P53

p57 Suppresses the Pluripotency and Proliferation of Mouse Embryonic Stem Cells by Positively Regulating p53 Activation

Essential Contribution Of Ets-1 To Constitutive Pim-3 Expression In Human Pancreatic Cancer Cells

Transcription activity is required for p53-dependent tumor suppression

p53 Regulates Hematopoietic Stem Cell Quiescence

Pwp1 is Required for the Differentiation Potential of Mouse Embryonic Stem Cells Through Regulating Stat3 Signaling

p53 Regulates Nuclear Architecture to Reduce Carcinogen Sensitivity and Mutagenic Potential